Search
for
Sort by
Research 841–870 of 1000+
- 180 Impact of underlying medical conditions and medications on edema development in alopecia patients receiving low-dose oral minoxidil (LDOM)
- Central serous chorioretinopathy after scalp and eyebrow intralesional triamcinolone acetonide injections: Report of two cases
- BH04 A global survey to assess practice of laboratory testing in alopecia areata by hair specialists
- Treatment Challenges in Alopecia Areata: Insights From a Case of Baricitinib Therapy Failure
- GLP‐1 agonists and hair loss: a call for further investigation
- Navigating Diagnostic Uncertainty: Frontal Fibrosing Alopecia Versus Keratosis Pilaris Atrophicans Faciei With Genetic Testing Insights
- Oral minoxidil and the exacerbation of alcohol hangover symptoms
- Scalp trauma in lichen planopilaris: Case reports of disease progression from fire fighter helmet use
- Response to Nathalie Y. Ly and colleagues “Medical and procedural treatment of androgenetic alopecia - Where are we?”
- Combating “Dread Shed”: The Impact of Overlapping Topical and Oral Minoxidil on Temporary Hair Shedding During Oral Minoxidil Initiation
- Response to “Low-dose oral minoxidil for androgenetic alopecia is not associated with clinically significant blood-pressure changes: a retrospective study”
- Examining the Uncertainties Surrounding Exosome Therapy in Androgenetic Alopecia: A Call for Evidence-Based Practice.
- Platelet-Rich Plasma Applications, The Past 5 Years: A Review Article
- Distribution of SALT scores by Therapeutic Tesponse in Patients with Severe Alopecia After 52 weeks of Baricitinib Therapy
- Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Treated With Baricitinib: An Update Through Week 152 From BRAVE-AA2
- Evaluating the role of COVID-19 vaccines in the landscape of medication-induced alopecia areata
- Evaluating subjective versus objective measures of changes in hair density using standardized scalp photography
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Sentiment analysis and natural language processing using Reddit data to evaluate patient opinions on hair loss therapeutics (Preprint)
- Intradermal Delivery of Alopecia Therapeutics: Current State and Future Prospects
- A case of cutis verticis gyrata developing in a patient with primary scarring alopecia: A unique presentation of a rare disorder
- Topical immunotherapies
- Enlarging alopecic patch in an African American woman with central centrifugal cicatricial alopecia: A case of concomitant tinea incognito
- Laboratory Testing in Telogen Effluvium
- 1300 Blood plasma levels of heart disease biomarker cardiac troponin I are significantly increased in alopecia areata affected individuals
- Styling without shedding: Novel topical formula reduces hair shedding by contracting the arrector pili muscle
- 556 α 1 -AR agonist induced piloerection protects against the development of traction alopecia